Member Info for ciaskin

Correct.

I've had a reply from CEPI. The event is at 1pm tomorrow and they have included a press release which is under strict embargo until 10th March 2021, 00.01GMT/ 01.01CET.

I've just emailed CEPI press office to find out more...

I missed the last paragraph of the Telegraph article when I first read it, but it says:

"Cepi is funded by governments and global philanthropic organisations, including the Bill and Melinda Gates Foundation and the Wellcome Trust. The organisation is set to outline its priorities for the next five years, including how to prevent the next pandemic, at a high-profile event on Wednesday this week."

That's tomorrow, guys and gals...

GLA

What's more, Scancell is already well and truly on CEPI's radar. This is taken from a blog posted on their website only last week (apologies if already posted):

"Instead of using the spike protein of SARS-CoV-2, which is prone to mutations, as the key target for coronavirus vaccines, researchers are assessing other parts of the virus that are known to be more stable.

For example, scientists at the University of Nottingham in the UK are working alongside pharmaceutical company Scancell and Nottingham Trent University to test its COVID-19 vaccine candidate, SN14, which targets both the spike protein as well as the nucleocapsid, or N-protein. By targeting this additional viral structure, which is far less likely to mutate, the vaccine if found safe and effective could work to protect people against COVID-19 irrespective of any mutations to the spike protein and, in theory, could work across other coronaviruses."

Full text is here:

https://cepi.net/news_cepi/going-universal-the-search-for-an-all-in-one-coronavirus-vaccine/

GLA

You may not have too long to wait, Crumbs...

Dr Richard Hatchett, chief executive of Cepi, told The Telegraph: “In the next couple of weeks we’ll be announcing a very significant investment in developing broadly protecting or even universal coronavirus vaccine.”

The Telegraph article release at lunchtime today says : 'The hunt for a vaccine that protects against all Covid-19 variants as well as other coronaviruses is set to heat up with “nine-figure” funding injection, The Telegraph can reveal.'

If my maths are correct, that means CEPI will be throwing at least 100 million at this. Pounds, Euros or Dollars? Frankly, I don't mind - especially as Scancell are mentioned in the very same article!!!
Thanks Wild - you have made me my day!

I agree entirely, Ray - I'm certain they are referring to Covidity, especially as it was the Telegraph that claimed the 'exclusive' (along with so many other newspapers!!) on Feb 13th:

Alongside scientists from the University of Nottingham, Scancell is targeting a protein in the core of the virus called the nucleocapsid or “N” protein, as well as the spike protein. Human trials of their vaccine will begin in the second half of this year, after positive results from testing the jab on mice. The DNA-based product seems to stimulate a good antibody and T-cell response. Scancell chief medical officer Dr Gillies O’Bryan-Tear, told The Telegraph: “We don’t necessarily claim it will be a pan-coronavirus vaccine, but it has got the potential to be so simply because of where it is targeted.”

Today's article, which says:

"A universal vaccine that would work on all Covid-19 variants by targeting the core of the virus instead of just the spike protein could be available in as little as a year, researchers say"

also reprises another part of the Feb 13th article which says:

"Scancell has had funding from the British government agency, Innovate UK, but needs a big pharmaceutical partner in order to progress its candidate, as well as hundreds of millions of pounds of investment, the team said. With this in place, and positive results from phase I/II trials, its candidate could be developed within a year."

So yes, I believe they ARE talking about Covidity in today's 'Latest Updates' article today and, for completeness, here's the link to their original 'exclusive' last month:

https://www.telegraph.co.uk/global-health/science-and-disease/exclusive-universal-vaccine-can-conquer-covid-variants-could/

AIMHO. GLA etc...

Sorry to change the subject, but the Daily Telegraph have posted a new article on their website at 8.28 this morning which provides a very comprehensive 'where are we now' viewpoint of vaccine developments. There's nothing in it that is particularly new but it is a useful summary and reaffirmation of where we are and I particularly liked:

On Mar 3, the Chancellor confirmed during his Budget announcement, an additional £1.6 billion for the coronavirus vaccine roll-out and to "improve future preparedness".

While tweaked vaccines which can battle variants will be rolled out without new approval or lengthy clinical trials, the Medicines and Healthcare products Regulatory Agency (MHRA) confirmed on Mar 4, a decision which will rapidly speed up their deployment.

A universal vaccine that would work on all Covid-19 variants by targeting the core of the virus instead of just the spike protein could be available in as little as a year, researchers say.

Dr June Raine, Chief Executive of the MHRA, said: "As of today there's no imperative that we fast-track a new variant-effective vaccine - but we are prepared."

The full article is here:
https://www.telegraph.co.uk/global-health/0/vaccine-covid-19-news-latest-uk-update-coronavirus-eligible/

and I would not be at all surprised if it appeared as a feature in tomorrow's print edition of the newspaper.

GLA.

May take on it is is that SCLP recognises that there has been huge media coverage over the last fortnight, resulting in a near doubling in the share price and dozens of new investors - but they have been attracted primarily by the promise of the Universal Covid vaccine. However, as all of us long-term holders know, SCLP is so much more than Covidity: it is, first and foremost, a cancer immunology company and I think the investors' presentation was mainly for the benefit of these NEW investors - to let them know that we are so much more than a Covid one-trick pony and to bring them up to speed with what the rest of us already know about the entire product pipeline.

In other words, it was to educate, open their eyes to the bigger picture, and to keep them on board for the longer run.

So yes, nothing earth-shatteringly new - and Cliff was as solid and dependable as ever (y'know) - but as an educational exercise for the new intake, I'd say 'job done'.

GLA. AIMHO etc...

V o x markets

The asterisked word is **********...

Try re-registering - worked for me

https://**********.brand.live/c/vox-markets-and-turner-pope-webinar-thursday-february-25th-

Ignore me. Just re-registered and I'm in!

Hi Guys. I registered on Monday and received a confirmation of registration, but nothing since - no link or anything like that. Before I get on to them, I I missing something obvious?

Up to 25.5/26.5 at the bell.

Another assault on 28p tomorrow...?

I agree, Wild. Tune in same time, same place next week?

Also, remember anyone can email the show with a question via vaccine @ bbc.co.uk

GLA!

Also the lady panellist, Professor Emma Thomson from the University of Glasgow sits on the COG-UK consortium...
...as does Professor Jonathan Ball from the University of Nottingham.

The stars are aligning, methinks?

GLA

According to Peter Hotez, MD, PhD at 11.54

It's a live show and they always try to keep it as topical and current as possible. All I know is that they have been alerted to the UoN Universal Vaccine and today's show is called 'Vaccines and Variants' so it may well touch on the Universal solution.